95 related articles for article (PubMed ID: 22404716)
41. Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice.
Khalil A; Goodhand JR; Wahed M; Yeung J; Ali FR; Rampton DS
Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1029-35. PubMed ID: 21857526
[TBL] [Abstract][Full Text] [Related]
42. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
43. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
[TBL] [Abstract][Full Text] [Related]
44. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET.
Komajda M; Anker SD; Charlesworth A; Okonko D; Metra M; Di Lenarda A; Remme W; Moullet C; Swedberg K; Cleland JG; Poole-Wilson PA
Eur Heart J; 2006 Jun; 27(12):1440-6. PubMed ID: 16717081
[TBL] [Abstract][Full Text] [Related]
45. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.
Auerbach M; Ballard H; Trout JR; McIlwain M; Ackerman A; Bahrain H; Balan S; Barker L; Rana J
J Clin Oncol; 2004 Apr; 22(7):1301-7. PubMed ID: 15051778
[TBL] [Abstract][Full Text] [Related]
46. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
Klinger M; Arias M; Vargemezis V; Besarab A; Sulowicz W; Gerntholtz T; Ciechanowski K; Dougherty FC; Beyer U
Am J Kidney Dis; 2007 Dec; 50(6):989-1000. PubMed ID: 18037099
[TBL] [Abstract][Full Text] [Related]
48. Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.
Germain M; Ram CV; Bhaduri S; Tang KL; Klausner M; Curzi M
Nephrol Dial Transplant; 2005 Oct; 20(10):2146-52. PubMed ID: 15985516
[TBL] [Abstract][Full Text] [Related]
49. Prevalence and determinants of anemia in the immediate postkidney transplant period.
Poesen R; Bammens B; Claes K; Kuypers D; Vanrenterghem Y; Monbaliu D; Evenepoel P
Transpl Int; 2011 Dec; 24(12):1208-15. PubMed ID: 21929730
[TBL] [Abstract][Full Text] [Related]
50. Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrectomy for cancer.
Yoon HM; Kim YW; Nam BH; Reim D; Eom BW; Park JY; Ryu KW
World J Gastroenterol; 2014 Feb; 20(7):1852-7. PubMed ID: 24587663
[TBL] [Abstract][Full Text] [Related]
51. Preoperative management of colorectal cancer-induced iron deficiency anemia in clinical practice: data from a large observational cohort.
Laso-Morales M; Jericó C; Gómez-Ramírez S; Castellví J; Viso L; Roig-Martínez I; Pontes C; Muñoz M
Transfusion; 2017 Dec; 57(12):3040-3048. PubMed ID: 28833205
[TBL] [Abstract][Full Text] [Related]
52. Effect of intravenous iron on outcomes of acute kidney injury.
Clark BA; Osadchuk L; John J; Culver T; Marcus R
Transfusion; 2016 Apr; 56(4):933-7. PubMed ID: 26801821
[TBL] [Abstract][Full Text] [Related]
53. Effects of Chronic Physical Activity on Glomerular Filtration Rate, Creatinine, and the Markers of Anemia of Kidney Transplantation Patients.
Lima PS; Campos ASD; Corrêa CS; Dias CJM; Mostarda CT; Amorim CEN; Garcia AMC
Transplant Proc; 2018 Apr; 50(3):746-749. PubMed ID: 29661428
[TBL] [Abstract][Full Text] [Related]
54. The impact of timing of intravenous iron supplementation on preoperative haemoglobin in patients scheduled for major surgery.
Neef V; Baumgarten P; Noone S; Piekarski F; Triphaus C; Kleinerüschkamp A; Helmer P; Messroghli L; Zacharowski K; Choorapoikayil S; Meybohm P
Blood Transfus; 2022 May; 20(3):188-197. PubMed ID: 34059194
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of immediate postoperative intravenous iron supplementation after staged bilateral total knee arthroplasty.
Lee SS; Lee J; Moon YW
BMC Musculoskelet Disord; 2023 Jan; 24(1):17. PubMed ID: 36611148
[TBL] [Abstract][Full Text] [Related]
56. The effects of oral iron supplementation on the progression of anemia and renal dysfunction in patients with chronic kidney disease.
Kim SM; Lee CH; Oh YK; Joo KW; Kim YS; Kim S; Lim CS
Clin Nephrol; 2011 May; 75(5):472-9. PubMed ID: 21543028
[TBL] [Abstract][Full Text] [Related]
57. Clinical predictors of postoperative hemoglobin drift.
Grant MC; Whitman GJ; Savage WJ; Ness PM; Frank SM
Transfusion; 2014 Jun; 54(6):1460-8. PubMed ID: 24236570
[TBL] [Abstract][Full Text] [Related]
58. Target Hemoglobin May Be Achieved with Intravenous Iron Alone in Anemic Patients with Cardiorenal Syndrome: An Observational Study.
Ben-Assa E; Shacham Y; Shashar M; Leshem-Rubinow E; Gal-Oz A; Schwartz IF; Schwartz D; Silverberg DS; Chernin G
Cardiorenal Med; 2015 Oct; 5(4):246-53. PubMed ID: 26648941
[TBL] [Abstract][Full Text] [Related]
59. Benefits of pre-operative oral Sucrosomial® iron supplementation in cardiac surgery: influence of patient's baseline hemoglobin and gender.
Weltert LP; De Rosa A; Rondinelli MB; Falco M; Turani F; Pierelli L
Blood Transfus; 2023 Jul; 21(4):305-313. PubMed ID: 36580029
[TBL] [Abstract][Full Text] [Related]
60. Anemia and Erythrocytes: Behavior and Prevalence 1 Year After Kidney Transplant.
Rosales Morales KB; Pérez RE; Cancino López JD; Díaz ER; Chacón Pérez MJ; Zavalza Camberos PA; Cheng MDCA; Cedillo Galindo HA; Morinelli Astorquizaga MA; Trejo Villeda LEM; Sierra RP; Hernández Rivera JCH
Transplant Proc; 2020 May; 52(4):1169-1172. PubMed ID: 32164957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
